(Q46552846)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

title

Rifaximin dose-finding study for the treatment of small intestinal bacterial overgrowth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

small intestinal bacterial overgrowth

13 January 2020

main subject

0 references

author

Angelo Santoliquido

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

Roberto Antonio Flore

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

author name string

E C Lauritano

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

M Gabrielli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Lupascu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G Nucera

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

E Scarpellini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

F Vincenti

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G Cammarota

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

P Pola

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

G Gasbarrini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

A Gasbarrini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

language of work or name

English

0 references

publication date

1 July 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

Alimentary Pharmacology & Therapeutics

13 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

13 January 2020

page(s)

31-35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15963077%20AND%20SRC:MED&resulttype=core&format=json

Antimicrobial activity and spectrum of rifaximin, a new topical rifamycin derivative

13 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02516.X

Rifaximin versus chlortetracycline in the short-term treatment of small intestinal bacterial overgrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02516.X

Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02516.X

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02516.X

Effects of daily oral administration of rifaximin and neomycin on faecal aerobic flora in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02516.X